Table 2.
Quality assessment criteria
| |
Score |
|||
|---|---|---|---|---|
| 3 | 2 | 1 | 0 | |
|
Patients at baseline, number |
>151 |
101 to 150 |
51 to 100 |
<50 |
|
Follow-up time, years |
>3 or mean ≥3 |
3 |
2 |
≤1 |
|
Clinical criteria |
Established criteria for AD + DLB criteria from 2005 |
Established criteria for AD + DLB criteria from 1992 or 1996 |
Used criteria for one type of dementia |
No criteria used |
| Autopsy, % of participants | 100 | >50 | >25 | None |
AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; BNT, Boston naming test; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease evaluation; DRS, dementia rating scale; ESD, extended scale for dementia; HVLT-R Hopkins verbal learning test-revised; mMMS, modified mini-mental state examination; MMSE, mini mental state examination; MTS, 37 item mental test score.